Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

Multiple companies and organizations have announced early results about their COVID-19 vaccines. Here's what we know about ...

Private credit assets under management will move from roughly $13 trillion today to close to $20 trillion in the next four ...

The Global Diabetic Macular Edema Market is experiencing significant growth driven by rising diabetes prevalence and technological advancements in retinal diagnostics like OCT and AI-enabled imaging.

EMVision Medical Devices and Clever Culture Systems are among ASX healthcare companies reporting milestones reached in ...

The global market for pneumonia therapeutics is experiencing significant growth, driven by increasing healthcare expenditure in developed nations like Germany, Japan, Brazil, and the United States, ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...

By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to ...

Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...

In recent decades, merger and acquisition activity has sent long-standing Michigan businesses' leadership out-of-state and even the country.

A case in point is the dire need for new antimicrobials, but pharmaceutical companies have little financial incentive to ...